Market Overview

Sobi Names Linea Aspesi Vice President of Human Resources in North America


a pioneering international biopharmaceutical company dedicated to rare
and difficult-to-treat diseases, announced today the appointment of
Linea Aspesi as vice president of human resources for North America.

This press release features multimedia. View the full release here:

Sobi Names Linea Aspesi Vice President of Human Resources in North America (Photo: Business Wire)

Sobi Names Linea Aspesi Vice President of Human Resources in North America (Photo: Business Wire)

Aspesi has 20 years' experience in human resources, which she will apply
to support Sobi's growth in North America. She will be responsible for
talent acquisition, management and retention; performance management;
total rewards; organizational design; employee relations; and
collaboration with Sobi's global human resources function.

Aspesi most recently served as head of human resources, Industrial
Affairs in the U.S. for Sanofi, where she was responsible for shaping,
driving and executing talent strategies and helping to transform the
3,000-employee Industrial Affairs North American organization. She also
previously supported the Sanofi Genzyme commercial business unit,
gaining experience in the rare disease field. Prior to that she held
multiple positions of increasing responsibility with the Sanofi human
resources department, receiving four promotions in six years. Before
joining Sanofi, Aspesi held HR positions at multiple organizations
including UMass Memorial Medical Center, Partners Healthcare System
Inc., Benchmarking Partners Inc., HealthSouth and others. She currently
serves on the board of directors for Partnerships for a Skilled
Workforce and for Seaglass Village.

"Sobi is committed to growing our footprint in North America, and
Linea's experience both recruiting and developing teams will be critical
to support this effort," said Rami Levin, President of Sobi in North

"The Sobi team is passionate about serving patients, and that passion –
combined with the depth of subject matter expertise each employee brings
to the table – provides a strong base on which to develop and grow this
organization," said Aspesi. "I look forward to supporting Sobi in
achieving its vision of becoming a leader in the rare disease field."

About Sobi™

Sobi is an international specialty healthcare company dedicated to rare
diseases. Sobi's mission is to develop and deliver innovative therapies
and services to improve the lives of patients. The product portfolio is
primarily focused on Haemophilia, Inflammation and Genetic diseases.
Sobi also markets a portfolio of specialty and rare disease products
across Europe, the Middle East, North Africa and Russia for partner
companies. Sobi is a pioneer in biotechnology with world-class
capabilities in protein biochemistry and biologics manufacturing. In
2016, Sobi had total revenues of SEK 5.2 billion (USD 608 M) and about
760 employees. The share (STO: SOBI) is listed on Nasdaq Stockholm. More
information is available at

View Comments and Join the Discussion!